- Market & Economic Perspectives
The new Alzheimer's drug from Biogen may be a boon for biotech, but investors have reasons to be wary.
- The Retirement Plan Advisor
PEPs offer unrelated businesses a pooling option for retirement plans, but is the solution too rigid? Learn why bundled solutions may be more flexible option for plan sponsor clients.
- The Fee-Only Advisor
Making the move to fee-only means saying goodbye your legacy commission accounts. Explore options for keeping your relationships after you walk away from the revenue.
- Cybersecurity & Enterprise Risk
When working with third-party vendors, knowledge isn’t just power—it’s also protection.
- Wealth Planning & Investing
Women often take a harder financial hit after divorce and ending a marriage post-pandemic is even more likely to interrupt a woman’s financial path.